Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

News:2021-05-11/Policy/china-schedules-synthetic-cannabinoids-as-a-full-class-of-controlled-substances-effective-1-july-2021

From Landrace.wiki
News record11 May 2021Policy
China schedules synthetic cannabinoids as a full class of controlled substances, effective 1 July 2021
The Ministry of Public Security, the National Health Commission and the National Medical Products Administration jointly announced class-wide scheduling of synthetic cannabinoids together with eighteen other new psychoactive substances, to take effect on 1 July 2021. Officials said 103 synthetic cannabinoids had been detected domestically out of 297 known worldwide, and described China as the first country to schedule the class as a whole. The announcement notes that these compounds do not depend on cannabis cultivation, being laboratory analogues rather than plant material.
maintained by landrace.wiki editors · page history
Date11 May 2021
CategoryPolicy
CountryChina
Agency公安部 (Ministry of Public Security); 国家卫生健康委员会 (National Health Commission); 国家药品监督管理局 (National Medical Products Administration)

2021-05-11 Policy China schedules synthetic cannabinoids as a full class of controlled substances, effective 1 July 2021 The Ministry of Public Security, the National Health Commission and the National Medical Products Administration jointly announced class-wide scheduling of synthetic cannabinoids together with eighteen other new psychoactive substances, to take effect on 1 July 2021. Officials said 103 synthetic cannabinoids had been detected domestically out of 297 known worldwide, and described China as the first country to schedule the class as a whole. The announcement notes that these compounds do not depend on cannabis cultivation, being laboratory analogues rather than plant material. http://www.nncc626.com/2021-05/12/c 1211152297.htm China 公安部 (Ministry of Public Security); 国家卫生健康委员会 (National Health Commission); 国家药品监督管理局 (National Medical Products Administration)